Personalising treatment of inflammatory autoimmune arthritis: immune regulation and the microbiome
Professor Thomas is a graduate of the University of Western Australia. She received her MBBS in 1984, and then trained in Perth as a rheumatologist. She commenced a research fellowship with Peter Lipsky at Southwestern Medical Center, University of Texas in 1990, where she first identified and characterised human circulating dendritic cell precursors. She is now Professor of Rheumatology at University of Queensland, Translational Research Institute, consultant rheumatologist at Princess Alexandra Hospital and fellow of the Australian Academy of Health and Medical Sciences.
Her research is focussed on the study of autoimmune disease and restoration of tolerance. Through this work, she developed and tested the first rheumatoid arthritis vaccine. She has also contributed major insights into the pathogenesis of spondyloarthropathy and autoimmune diabetes, leading to the development of disease biomarkers and therapeutic strategies. Ranjeny is founder and a director of the spin-off company, Dendright, which is developing vaccines to suppress autoimmune diseases.
Date: 4 July 2017, 12:00 (Tuesday, 11th week, Trinity 2017)
Venue: Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details: Bernard Sunley Lecture Theatre
Speaker: Professor Ranjeny Thomas (Arthritis Queensland Chair in Rheumatology)
Organising department: Kennedy Institute of Rheumatology
Organiser: Gintare Kolesnikovaite (Kennedy Institute of Rheumatology)
Organiser contact email address: Gintare.Kolesnikovaite@kennedy.ox.ac.uk
Host: Prof Fiona Powrie (PROFESSOR OF MUSCULOSKELETAL SCIENCES AND DIRECTOR OF THE KENNEDY INSTITUTE)
Part of: Kennedy Institute Seminars
Booking required?: Not required
Audience: Members of the University only
Editor: Gintare Kolesnikovaite